T1	Outcomes 19 164	expression of c-erbB-2/neu oncoprotein, epidermal growth factor receptor, cathepsin D, progesterone receptor and tumor associated glycoprotein-72
T2	Outcomes 358 531	expression of neu/c-erbB-2 oncoprotein, epidermal growth factor receptor (EGFR), cathepsin D (catD), progesterone receptor (PR) and tumor-associated glycoprotein-72 (TAG-72)
T3	Outcomes 772 794	Neu oncoprotein and PR
T4	Outcomes 814 820	ELISA.
T5	Outcomes 821 836	CatD and TAG-72
T6	Outcomes 858 890	immunoradiometric (IRMA) methods
T7	Outcomes 896 940	EGFR were studied by radioimmunoassay (RIA).
T8	Outcomes 949 990	Neu, EGFR, catD and TAG-72 concentrations
T9	Outcomes 1116 1138	catD and PR expression
T10	Outcomes 1199 1219	TAG-72 concentration
T11	Outcomes 1243 1246	neu
T12	Outcomes 1335 1362	EGFR and neu concentrations
T13	Outcomes 1432 1458	PR and catD concentrations
T14	Outcomes 1513 1519	TAG-72
